Sai Life Sciences Statistics

Total Valuation

Sai Life Sciences has a market cap or net worth of INR 148.22 billion. The enterprise value is 156.06 billion.

Market Cap	148.22B
Enterprise Value	156.06B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.34%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	64.97M

Valuation Ratios

The trailing PE ratio is 119.78.

PE Ratio	119.78
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	14.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 45.88, with an EV/FCF ratio of 1,019.37.

EV / Earnings	126.11
EV / Sales	10.42
EV / EBITDA	45.88
EV / EBIT	70.54
EV / FCF	1,019.37

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.95.

Current Ratio	1.22
Quick Ratio	0.97
Debt / Equity	0.95
Debt / EBITDA	2.92
Debt / FCF	64.98
Interest Coverage	2.56

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	4.78M
Profits Per Employee	394,721
Employee Count	2,845
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.76
Average Volume (20 Days)	178,446

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sai Life Sciences had revenue of INR 14.98 billion and earned 1.24 billion in profits. Earnings per share was 6.66.

Revenue	14.98B
Gross Profit	10.49B
Operating Income	2.21B
Pretax Income	1.66B
Net Income	1.24B
EBITDA	3.03B
EBIT	2.21B
Earnings Per Share (EPS)	6.66

Full Income Statement

Balance Sheet

The company has 2.12 billion in cash and 9.95 billion in debt, giving a net cash position of -7.83 billion.

Cash & Cash Equivalents	2.12B
Total Debt	9.95B
Net Cash	-7.83B
Net Cash Per Share	n/a
Equity (Book Value)	10.46B
Book Value Per Share	56.80
Working Capital	1.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.43 billion and capital expenditures -2.28 billion, giving a free cash flow of 153.09 million.

Operating Cash Flow	2.43B
Capital Expenditures	-2.28B
Free Cash Flow	153.09M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.03%, with operating and profit margins of 14.77% and 8.26%.

Gross Margin	70.03%
Operating Margin	14.77%
Pretax Margin	11.10%
Profit Margin	8.26%
EBITDA Margin	20.24%
EBIT Margin	14.77%
FCF Margin	1.02%

Dividends & Yields

Sai Life Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.34%
Shareholder Yield	-2.34%
Earnings Yield	0.94%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sai Life Sciences has an Altman Z-Score of 1.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.32
Piotroski F-Score	n/a